NCT04026438View on ClinicalTrials.gov

Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT)

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

February 24, 2021

Study Completion Date

February 24, 2021

Conditions
Complication, PostoperativeRegeneration Liver
Interventions
DRUG

Potassium Phosphate Injection

One ml of the preparation contains 3 mmol of phosphorous which when equated with RDA 10ml ie 30 mmol of preparation will be supplemented. The preparation is given slowly, intravenously over 4 hours diluted in 500 ml normal saline

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT04026438 - Randomized Controlled Trial to Study the Outcome of Intravenous Phosphate Supplementation in Live Donors Undergoing Hepatectomy for Living Donor Liver Transplantation (LDLT) | Biotech Hunter | Biotech Hunter